In February 2004, the Food and Drug Administration approved the chemotherapy drug Pemetrexed (which is marketed under the brand name Alimta) for the treatment of malignant pleural mesothelioma. Pemetrexed in combination with the …
More: continued here
Blogsphere: TechnoratiFeedsterBloglines
Bookmark: Del.icio.usSpurlFurlSimpyBlinkDigg
RSS feed for comments on this post | TrackBack URI for this post
Best Deal Ads :






